Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Major purpose of this research is to evaluate the effect and usefulness of Buprenorphine
transdermal system (MTDS) among the patients with lumbar spinal disease who was performed the
single-level posterior lumbar fusion.
After surgery, all the patients apply the patient-controlled analgesia. After three days of
surgery, patients are divided into two groups.Group A is an experimental group that
administer the BTDS after surgery, and Group B is a control group that take tramadol
analgesics. If the patient's pain score exceeds the NRS 4, they can take the additional
rescue medicine, acetaminophen.
After the surgery, patient's pain score and quality of life would be recorded sequentially.
The time of recording is postoperative 36 hours, 72 hours, 7 days, 2 weeks, 4 weeks, and 3
months, respectively.